Coreline Soft Showcases Innovative AI Medical Imaging at STR 2025 Conference

Coreline Soft, a leader in AI-based medical imaging, is set to demonstrate its groundbreaking thoracic imaging solutions at the much-anticipated Society of Thoracic Radiology (STR) 2025 conference. The event is slated to take place from March 1 to 5, 2025, at the Hyatt Huntington Beach in California, gathering global radiology experts to exchange ideas and advancements in the field.

During this significant event, Coreline Soft will present its impressive AVIEW lineup, which incorporates advanced AI technologies focused on lung and thoracic diagnostics. The AVIEW LCS system, recently recognized for its remarkable accuracy in first-reading performance by the European Journal of Cancer, will be a highlight. Additionally, the company will showcase AVIEW Lung Texture, a sophisticated software providing fully automated and quantitative analysis for interstitial lung disease (ILD), and AVIEW COPD, designed for automatic evaluation of chronic obstructive pulmonary disease.

James Lee, the Head of Coreline North America, shared insights into the increasing relevance of AI in medical diagnostics. He noted, "Last year, numerous thoracic disease conferences in the U.S. emphasized the need for quantitative analysis of conditions like COPD and ILD through AI, underlining its potential to accurately predict treatment outcomes and prognosis."

Lee pointed out the vital role that partnerships between pharmaceutical companies and AI technology firms will play in developing precise data analysis crucial for new drug development. This collaboration aims to foster innovation and streamline diagnostic processes across the medical field.

At STR 2025, Coreline Soft sees a prime opportunity to demonstrate its recognized capabilities in quantitative analysis technology for lung disease diagnosis. The company is committed to expanding collaborative efforts with medical platforms globally, particularly in the U.S., to enhance companion testing and develop comprehensive diagnostic solutions.

Coreline Soft's dedication to advancing AI-based thoracic imaging positions it at the forefront of medical imaging innovation. The company provides quantitative analysis solutions for critical respiratory diseases, including lung cancer, COPD, and ILD, addressing a crucial need within the healthcare industry.

Furthermore, Coreline North America has established collaborations with major medical institutions, such as the Temple Lung Center, and is fostering relationships with leading organizations like the Mount Sinai Respiratory Institute. This strategic positioning allows Coreline Soft to expand its market presence and leverage partnerships for enhanced patient care.

In addition to its participation in STR 2025, Coreline Soft is also set to showcase its innovations at the 2025 HIMSS Global Health Conference and Exhibition, the largest medical IT event worldwide, taking place on March 3 in Las Vegas. The company recently achieved compliance certification with both the U.S. Health Insurance Portability and Accountability Act (HIPAA) and the European General Data Protection Regulation (GDPR), reinforcing its commitment to data security and patient privacy.

As it prepares for these pivotal events, Coreline Soft aims to underline its contributions to transforming the thoracic imaging landscape through AI, ultimately improving diagnostic accuracy and patient outcomes across the global healthcare system.